Laura G. Eichorn is Chief Financial Officer of Imago BioSciences, Inc.. Currently has a direct ownership of 0 shares of IMGO, which is worth approximately $0. The most recent transaction as insider was on Jan 11, 2023, when has been sold 246,453 shares (Common Stock) at a price of $36.0 per share, resulting in proceeds of $8,872,308. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 0
0% 3M change
0% 12M change
Total Value Held $0

Laura G. Eichorn Transaction History

Date Transaction Value Shares Traded Shares Held Form
Jan 11 2023
BUY
Disposition due to a tender of shares in a change of control transaction
$8,872,308 $36.0 p/Share
246,453 Added 100.0%
0 Common Stock
Jan 03 2023
BUY
Exercise of conversion of derivative security
$364,879 $9.83 p/Share
37,119 Added 13.09%
246,453 Common Stock
Dec 27 2022
SELL
Open market or private sale
$111,383 $35.93 p/Share
3,100 Reduced 1.47%
207,737 Common Stock
Dec 27 2022
BUY
Exercise of conversion of derivative security
$7,812 $2.52 p/Share
3,100 Added 1.45%
210,837 Common Stock
Dec 15 2022
SELL
Open market or private sale
$4,535,094 $35.79 p/Share
126,714 Reduced 37.89%
207,737 Common Stock
Dec 15 2022
BUY
Exercise of conversion of derivative security
$268,633 $2.12 p/Share
126,714 Added 27.48%
334,451 Common Stock
Nov 02 2022
SELL
Open market or private sale
$9,954 $18.0 p/Share
553 Reduced 0.27%
207,737 Common Stock
Nov 02 2022
BUY
Exercise of conversion of derivative security
$1,393 $2.52 p/Share
553 Added 0.26%
208,290 Common Stock
Aug 22 2022
SELL
Open market or private sale
$8,046 $18.0 p/Share
447 Reduced 0.21%
207,737 Common Stock
Aug 22 2022
BUY
Exercise of conversion of derivative security
$1,126 $2.52 p/Share
447 Added 0.21%
208,184 Common Stock
Aug 17 2022
SELL
Open market or private sale
$7,274 $19.5 p/Share
373 Reduced 0.18%
207,737 Common Stock
Aug 17 2022
BUY
Exercise of conversion of derivative security
$940 $2.52 p/Share
373 Added 0.18%
208,110 Common Stock
Aug 16 2022
SELL
Open market or private sale
$10,394 $19.5 p/Share
533 Reduced 0.26%
207,737 Common Stock
Aug 16 2022
BUY
Exercise of conversion of derivative security
$1,343 $2.52 p/Share
533 Added 0.26%
208,270 Common Stock
Jul 20 2022
SELL
Open market or private sale
$18,000 $18.0 p/Share
1,000 Reduced 0.48%
207,737 Common Stock
Jul 20 2022
BUY
Exercise of conversion of derivative security
$2,520 $2.52 p/Share
1,000 Added 0.48%
208,737 Common Stock
Feb 22 2022
SELL
Open market or private sale
$174,960 $21.87 p/Share
8,000 Reduced 3.71%
207,737 Common Stock
Feb 22 2022
BUY
Exercise of conversion of derivative security
$20,160 $2.52 p/Share
8,000 Added 3.58%
215,737 Common Stock
Feb 11 2022
SELL
Open market or private sale
$94,440 $23.61 p/Share
4,000 Reduced 1.89%
207,737 Common Stock
Feb 11 2022
BUY
Exercise of conversion of derivative security
$6,080 $1.52 p/Share
4,000 Added 1.85%
211,737 Common Stock
Feb 09 2022
SELL
Open market or private sale
$86,240 $21.56 p/Share
4,000 Reduced 1.89%
207,737 Common Stock
Feb 09 2022
BUY
Exercise of conversion of derivative security
$6,080 $1.52 p/Share
4,000 Added 1.85%
211,737 Common Stock
Jan 12 2022
SELL
Open market or private sale
$159,680 $19.96 p/Share
8,000 Reduced 3.71%
207,737 Common Stock
Jan 12 2022
BUY
Exercise of conversion of derivative security
$12,160 $1.52 p/Share
8,000 Added 3.58%
215,737 Common Stock
LGE

Laura G. Eichorn

Chief Financial Officer
South San Francisco, CA

Track Institutional and Insider Activities on IMGO

Follow Imago BioSciences, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells IMGO shares.

Notify only if

Insider Trading

Get notified when an Imago Bio Sciences, Inc. insider buys or sells IMGO shares.

Notify only if

News

Receive news related to Imago BioSciences, Inc.

Track Activities on IMGO